Drug intelligence / Profile preview

Seboral

Development stage
Unknown
Lead developer
Pelpharma Handels
Modality
Small Molecules
Administration
Topical
01

Overview

Seboral is a topical dermatological solution marketed by Pelpharma Handels, primarily indicated for the treatment of dandruff, seborrhea, and itchy scalp. It is a combination product containing **resorcinol** and **salicylic acid** as its primary active ingredients. Salicylic acid functions as a keratolytic agent by softening keratin and promoting the exfoliation of the stratum corneum, which helps clear scales associated with seborrheic dermatitis. Resorcinol complements this action with its own keratolytic and antiseptic properties, helping to reduce scalp irritation and manage microbial activity. The formulation is typically used as a hair tonic for direct application to the scalp to alleviate flaking and pruritus.

Brand names
Seboral
Other names
Seboral Haartonicum
02

Targets

CYP51A1 (Sterol 14α-demethylase)

Beyond the preview

Go deeper on Seboral.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seboral.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call